Terms: = Brain cancer AND CARS, P49589, 833, ENSG00000110619 AND Prognosis
16 results:
1. Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.
Wang H; Zeng L; Wu H; Tian J; Xie H; Zhang L; Ran Q; Zhong P; Chen L; Yi L; Wang S
Eur Radiol; 2024 Mar; 34(3):1982-1993. PubMed ID: 37658897
[TBL] [Abstract] [Full Text] [Related]
2. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients.
Ferrer VP
Cancer Genet; 2023 Jan; 270-271():22-30. PubMed ID: 36436416
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
4. Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma.
Verma A; Rafiq S
Cancer Treat Res; 2022; 183():161-184. PubMed ID: 35551659
[TBL] [Abstract] [Full Text] [Related]
5. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract] [Full Text] [Related]
6. Chimeric Antigen Receptor T Cells for Glioblastoma: Current Concepts, Challenges, and Future Perspectives.
Karschnia P; Teske N; Thon N; Subklewe M; Tonn JC; Dietrich J; von Baumgarten L
Neurology; 2021 Aug; 97(5):218-230. PubMed ID: 33986138
[TBL] [Abstract] [Full Text] [Related]
7. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
[TBL] [Abstract] [Full Text] [Related]
8. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of FBXO17 gene expression in high-grade glioma.
Du D; Yuan J; Ma W; Ning J; Weinstein JN; Yuan X; Fuller GN; Liu Y
BMC Cancer; 2018 Jul; 18(1):773. PubMed ID: 30064493
[TBL] [Abstract] [Full Text] [Related]
10. Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons.
Choi BD; Curry WT; Carter BS; Maus MV
Neurosurg Focus; 2018 Jun; 44(6):E13. PubMed ID: 29852773
[TBL] [Abstract] [Full Text] [Related]
11. A predicted model for postoperative seizure outcomes after the surgical resection of supratentorial cavernous malformations.
Wang C; Yu X; Shrestha S; Qian C; Wang L; Chen G
Medicine (Baltimore); 2016 Jun; 95(26):e4078. PubMed ID: 27368051
[TBL] [Abstract] [Full Text] [Related]
12. IVIM perfusion fraction is prognostic for survival in brain glioma.
Federau C; Cerny M; Roux M; Mosimann PJ; Maeder P; Meuli R; Wintermark M
Clin Neuroradiol; 2017 Dec; 27(4):485-492. PubMed ID: 27116215
[TBL] [Abstract] [Full Text] [Related]
13. Novel mechanisms and approaches in immunotherapy for brain tumors.
Finocchiaro G; Pellegatta S
Discov Med; 2015; 20(108):7-15. PubMed ID: 26321082
[TBL] [Abstract] [Full Text] [Related]
14. Model T muscle cars can treat brain tumors.
Johnson LA
Clin Cancer Res; 2012 Nov; 18(21):5834-6. PubMed ID: 23019306
[TBL] [Abstract] [Full Text] [Related]
15. cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.
Kim YW; Kwon C; Liu JL; Kim SH; Kim S
PLoS One; 2012; 7(8):e40960. PubMed ID: 22952576
[TBL] [Abstract] [Full Text] [Related]
16. Multidrug resistance transporters and modulation.
Tan B; Piwnica-Worms D; Ratner L
Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
[TBL] [Abstract] [Full Text] [Related]
